Figure 2.
The results of investigations into the effect of miR-520a on the levels of the surface antigen of the hepatitis B virus (HBsAg) and hepatitis B e-antigen (HBeAg) in the supernatant from HepG2.2.15 cells at different time-points after transfection with a miR-520a mimic or a miR-520a inhibitor. The data are presented as mean ± SD from three independent experiments; Student’s t-test; *P < 0.05, **P < 0.01 compared with negative control (NC) group.